CN109674539B - Tumor marking device - Google Patents

Tumor marking device Download PDF

Info

Publication number
CN109674539B
CN109674539B CN201811617035.4A CN201811617035A CN109674539B CN 109674539 B CN109674539 B CN 109674539B CN 201811617035 A CN201811617035 A CN 201811617035A CN 109674539 B CN109674539 B CN 109674539B
Authority
CN
China
Prior art keywords
drug
layer
tumor
attachment layer
solid body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811617035.4A
Other languages
Chinese (zh)
Other versions
CN109674539A (en
Inventor
郭世龙
张雪
宋心如
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Third Affiliated Hospital of Xinxiang Medical University
Original Assignee
Third Affiliated Hospital of Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third Affiliated Hospital of Xinxiang Medical University filed Critical Third Affiliated Hospital of Xinxiang Medical University
Priority to CN201811617035.4A priority Critical patent/CN109674539B/en
Publication of CN109674539A publication Critical patent/CN109674539A/en
Application granted granted Critical
Publication of CN109674539B publication Critical patent/CN109674539B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3904Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
    • A61B2090/3908Soft tissue, e.g. breast tissue

Abstract

The invention belongs to the technical field of medical equipment, and particularly relates to a tumor marking device which comprises a solid body, wherein a drug attachment layer for attaching an anti-tumor drug is sheathed outside the solid body in a wrapping manner, a fixing layer is sheathed outside the drug attachment layer in a wrapping manner, and a plurality of drug outlets are formed in the fixing layer; and the solid body and the fixed layer are made of inert metal materials. The device of the invention has the functions of a drug carrier and a marking and positioning function, the drug can directly treat tumor tissues, and the inert metal material is convenient for identifying and tracking radiotherapy equipment.

Description

Tumor marking device
Technical Field
The invention belongs to the technical field of medical equipment, and particularly relates to a tumor marking device.
Background
The tumor can be positioned immediately after being marked, so that the radiotherapy equipment can be positioned to the tumor more accurately, the pertinence and accuracy of radiotherapy are improved, the damage to the healthy tissues of a human body is reduced, and the pain of a patient is relieved. For example, chinese patent CN 207085091U discloses a tumor marker device, which includes a marking unit, where the marking unit includes a spherical mark and a truncated cone-shaped mark, the bottom of the truncated cone-shaped mark is connected to the spherical mark, the axis of the truncated cone-shaped mark passes through the spherical center of the spherical mark, and the marking unit is made of titanium alloy. The titanium alloy material is an inert metal material, is easy to track and position, is harmless to a human body after being carried for a long time, and does not influence conventional medical examination. The device is directly placed in tumor tissues, and can shield signals sent by the therapeutic instrument, realize the positioning and tracking of tumors, and is convenient to use. Chinese patent CN 206809339U discloses a shallow cavity titanium marking device, which comprises a titanium feeding mechanism, a puncture needle and an ejection mechanism, and titanium particles are injected into a shallow lesion part by utilizing the device to mark a lesion area.
The marking device only has one function of marking and positioning and has no other functions. Although the adopted titanium material is not harmful to the human body, the titanium material is foreign matter to the human body after all, the implantation operation is not easy, if other structures can be added into the injected titanium material to ensure that the titanium material has the function of a drug therapy carrier, the dual effects can be achieved, after the tumor is positioned by using an instrument, a specific drug can be injected into a positioning point, and the tumor therapy effect can be greatly improved.
In summary, there is a need to develop a tumor marker device having both the drug carrier function and the marker localization function.
Disclosure of Invention
In order to solve the above problems, the present invention provides a tumor marker device, which has both the drug carrier function and the marker positioning function.
The tumor marking device provided by the invention comprises a solid body, wherein a drug attachment layer for attaching an anti-tumor drug is coated and sleeved outside the solid body, a fixing layer is coated and sleeved outside the drug attachment layer, and a plurality of drug outlets are formed in the fixing layer; and the solid body and the fixed layer are made of inert metal materials.
Preferably, in the tumor marker device, the shape of the drug outlet is an arc, a circle, a ring, or an irregularly shaped curve.
Preferably, in the tumor marking device, the shapes of the different medicine outlets on each fixing layer are not completely consistent.
Preferably, in the tumor marker device, the drug attachment layer is provided with a convex hemisphere.
Preferably, in the tumor marking device, the radius of the convex hemisphere is 0.01-0.01 mm.
Preferably, in the tumor marker device, the surface of the convex hemisphere and the surface of the drug attachment layer are both provided with a plurality of penetration holes.
Preferably, in the tumor marker device, the diameter of the penetration hole is less than or equal to 5 μm.
Preferably, in the tumor marking device, the solid cylinder, the drug attachment layer and the fixing layer are all cylindrical shells with non-open ends, and the solid cylinder, the drug attachment layer and the fixing layer are sequentially sleeved from inside to outside; or the solid body is a solid cylinder, the drug attachment layer and the fixing layer are both in the shape of a cylinder pipe with two open ends, and the drug attachment layer, the drug fixing layer and the fixing layer are sleeved in sequence from inside to outside; or the solid body, the drug attachment layer and the fixing layer are all spherical shell-shaped and are sleeved from inside to outside in sequence.
Preferably, in the tumor labeling device, the drug attachment layer is made of a medical polymer material, a natural polymer material, an inert metal material or a ceramic material.
Compared with the prior art, the tumor marking device provided by the invention at least has the following beneficial effects:
the solid body is used for supporting the whole tumor marking device, the drug attachment layer is used for attaching anti-tumor drugs, the fixing layer is used for contacting with the tumor and firmly fixing the tumor marking device on the tumor, long-term positioning is facilitated, and the drug outlet is used for enabling the drugs attached to the drug attachment layer to be smoothly dissolved into tumor tissues. The different medicine outlets on each fixing layer are not completely consistent in shape, different friction force, adhesion force and the like exist between the irregular medicine outlet and tumor tissues, and the tumor tissues are irregular in shape.
The device of the invention has the functions of a drug carrier and a marking and positioning function, and is placed in drug powder or a drug carrier for a period of time before being placed in tumor tissue, so that the drug is attached to the drug attachment layer and then is placed in the tumor tissue, and the drug directly has the treatment effect on the tumor tissue, and especially when the drug attachment layer is prepared by adopting a drug slow-release material, the long-acting and direct drug treatment effect can be realized. If the tumor marking device is a shallow cavity part such as an oral cavity, a cervix, a vagina and the like, the drug can be directly injected into the drug outlet of the tumor marking device again through the injector for chemotherapy, the device which is arranged in the tumor tissue is utilized to the maximum extent, and the operation of arranging other foreign matters in the body is reduced.
Drawings
FIG. 1 is a structural view of an appearance of a tumor marking apparatus according to example 1 of the present invention;
FIG. 2 is a perspective view of a tumor marker apparatus according to embodiment 1 of the present invention;
FIG. 3 is a schematic cross-sectional view of a tumor marker device according to example 2 of the present invention;
FIG. 4 is a schematic view of the surface structure of a drug-attached layer in example 2 of the present invention;
fig. 5 is a schematic structural diagram of a tumor marker device according to embodiment 4 of the present invention.
Description of reference numerals:
1. the medicine is characterized by comprising a solid body, 2 a medicine adhesion layer, 21 a convex hemisphere, 3 a fixing layer and 31 a medicine outlet.
Detailed Description
The following detailed description of the present invention is provided in conjunction with the accompanying drawings, but it should be understood that the scope of the present invention is not limited to the specific embodiments.
A tumor marking device is specifically shown in figures 1-5 and comprises a solid body 1, a drug attachment layer 2 is sleeved outside the solid body 1 in a wrapping mode, a fixing layer 3 is sleeved outside the drug attachment layer 2 in a wrapping mode, and the solid body 1, the drug attachment layer 2 and the fixing layer 3 are sequentially arranged from inside to outside. The solid body 1 is used for supporting the whole tumor marking device, the drug adhesion layer 2 is used for adhering anti-tumor drugs, such as drug powder or drug colloid, and the fixed layer 3 is used for being in contact with the tumor and enabling the tumor marking device to be firmly fixed on the tumor, so that long-term positioning is facilitated. In order to make the medicine attached on the medicine attaching layer 2 smoothly dissolve into the tumor tissue, a plurality of medicine outlets 31 are arranged on the fixing layer 3. The shape of the medicine outlet 31 is an arc, a circle, a ring or an irregular curve, the shapes of different medicine outlets 31 on each fixing layer 3 are not completely consistent, different friction force, adhesion force and the like exist between the irregular medicine outlet 31 and tumor tissues, and in addition, the shapes of the tumor tissues are irregular, the medicine outlets 31 with different shapes can be tightly combined with the tumor tissues, so that the stability of the tumor marking device on the tumor tissues is further improved.
The solid body 1 and the fixed layer 3 are made of inert metal materials, such as pure gold and titanium alloy, which are harmless to human body, can be used for a long time and are convenient for identifying and tracking radiotherapy equipment. The drug attachment layer 2 is made of a material with good biological compatibility or less harm to human body, such as medical high polymer materials like medical silica gel films and synthetic fibers, natural high polymer materials like albumin, polypeptides and natural rubber, inert metal materials like niobium-titanium alloy layers, and ceramic materials. The invention includes the following examples.
Example 1
A tumor marking device is shown in figures 1-2 and comprises a solid body 1, wherein a drug attachment layer 2 is coated and sleeved outside the solid body 1, and a fixing layer 3 is coated and sleeved outside the drug attachment layer 2; the solid body 1 is a solid cylinder, the drug attachment layer 2 and the fixing layer 3 are cylindrical shells with non-open ends, and the three are sleeved from inside to outside in sequence; or the solid body 1 is a solid cylinder, the drug attachment layer 2 and the fixing layer 3 are both cylindrical pipes with openings at two ends, and the three are sleeved from inside to outside in sequence; the medicine outlet 31 on the side wall of the fixed layer 3 is arc-shaped and semicircular. The solid body 1 and the fixed layer 3 are made of inert titanium alloy materials, and the drug attachment layer 2 is a niobium-titanium alloy layer.
Example 2
A tumor marker device having substantially the same structure as in example 1, except that: the drug attachment layer 2 is provided with a convex hemisphere 21, referring to fig. 3-4, the radius of the convex hemisphere 21 is 0.01-0.01mm, a gap is left between the drug attachment layer 2 and the fixed layer 3 due to the existence of the convex hemisphere 21, and drugs attached to the drug attachment layer 2 can extend into tumor tissues along the secondary gap.
Example 3
A tumor marker device having substantially the same structure as in example 2, except that: the surface of the convex hemisphere 21 and the surface of the drug attachment layer 2 are both provided with a plurality of permeation holes, and the diameters of the permeation holes are less than or equal to 5 microns. The arrangement of the permeation holes increases the contact area between the medicine and the medicine attachment layer 2, increases the medicine loading capacity and increases the medicine loading firmness. The drug attachment layer 2 is made of ceramic material.
Example 4
The utility model provides a tumour mark device, as shown in fig. 5, includes solid 1, and the outside cladding cover of solid 1 is equipped with medicine adhesion layer 2, and the outside cladding cover of medicine adhesion layer 2 is equipped with fixed bed 3, and solid 1, medicine adhesion layer 2, fixed bed 3 are the spherical shell shape, and the three overlaps from inside to outside in proper order and establish. The solid body 1 and the fixed layer 3 are made of inert titanium metal materials, the medicine adhesion layer 2 is made of a medical silica gel film, and the medicine outlet 31 in the fixed layer 3 is circular, arc-shaped or annular.
It should be noted that, the outer side wall of the fixing layer 3 of the tumor marker device in any of embodiments 1-4 may be fixed with an attachment ear, which is in the shape of an ellipsoid and is convenient for combining with tumor tissue.
It should be noted that the preferred embodiments of the present invention have been described for the sake of brevity, but that further variations and modifications of these embodiments may occur to those skilled in the art once they learn of the basic inventive concepts. Therefore, it is intended that the appended claims be interpreted as including preferred embodiments and all such alterations and modifications as fall within the scope of the invention.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.

Claims (3)

1. The tumor marking device is characterized by comprising a solid body (1), wherein a drug attachment layer (2) for attaching an anti-tumor drug is sheathed outside the solid body (1) in a wrapping manner, a fixing layer (3) is sheathed outside the drug attachment layer (2) in a wrapping manner, and a plurality of drug outlets (31) are formed in the fixing layer (3); the solid body (1) and the fixed layer (3) are made of inert metal materials; the shape of the medicine outlet (31) is arc, round, annular or irregular curve; a convex hemisphere (21) is arranged on the drug attachment layer (2), the radius of the convex hemisphere (21) is 0.01-0.01mm, a plurality of permeation holes are formed in the surface of the convex hemisphere (21) and the surface of the drug attachment layer (2), and the diameters of the permeation holes are less than or equal to 5 microns;
the solid body (1) is a solid cylinder, the drug attachment layer (2) and the fixing layer (3) are cylindrical shells with non-open ends, and the solid cylinder, the drug attachment layer and the fixing layer are sequentially sleeved from inside to outside; or the solid body (1) is a solid cylinder, the drug attachment layer (2) and the fixing layer (3) are both cylindrical pipes with openings at two ends, and the drug attachment layer, the drug attachment layer and the fixing layer are sequentially sleeved from inside to outside; or the solid body (1), the drug attachment layer (2) and the fixing layer (3) are all spherical shell-shaped and are sleeved from inside to outside in sequence.
2. Tumor marking device according to claim 1, characterized in that the shape of the different drug outlets (31) on each fixing layer (3) is not exactly uniform.
3. The tumor marking device according to claim 1 or 2, wherein the drug attachment layer (2) is made of a medical polymer material, a natural polymer material, an inert metal material, a drug slow release material or a ceramic material.
CN201811617035.4A 2018-12-28 2018-12-28 Tumor marking device Active CN109674539B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811617035.4A CN109674539B (en) 2018-12-28 2018-12-28 Tumor marking device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811617035.4A CN109674539B (en) 2018-12-28 2018-12-28 Tumor marking device

Publications (2)

Publication Number Publication Date
CN109674539A CN109674539A (en) 2019-04-26
CN109674539B true CN109674539B (en) 2022-01-21

Family

ID=66190791

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811617035.4A Active CN109674539B (en) 2018-12-28 2018-12-28 Tumor marking device

Country Status (1)

Country Link
CN (1) CN109674539B (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170066162A9 (en) * 2006-03-28 2017-03-09 Devicor Medical Products, Inc. Method of Enhancing Ultrasound Visibility of Hyperechoic Materials
CN105963806A (en) * 2016-04-28 2016-09-28 创领心律管理医疗器械(上海)有限公司 Auxiliary equipment and preparation method thereof
CN206372136U (en) * 2016-08-23 2017-08-04 北京大学深圳医院 Tumor of breast bulb positioner
CN106691598A (en) * 2017-02-06 2017-05-24 浙江荣诚医疗科技有限公司 Gold mark with coating and coating location device
CN106552326A (en) * 2017-02-06 2017-04-05 中国人民解放军总医院 Tumor-localizing device
CN106621076A (en) * 2017-02-06 2017-05-10 浙江荣诚医疗科技有限公司 Cobalt-zirconium gold marker implant and gold marker implantation apparatus
CN107715307A (en) * 2017-09-26 2018-02-23 李铭 A kind of tumor-localizing device

Also Published As

Publication number Publication date
CN109674539A (en) 2019-04-26

Similar Documents

Publication Publication Date Title
US8170647B2 (en) Fiduciary markers and method of use thereof
BRPI0518383A2 (en) Chargeable polymeric particles for therapeutical and / or diagnostic applications and methods for preparing and using them
US20060171895A1 (en) Medical imaging reference devices
US20040220444A1 (en) Positioning needle guide for brachytherapy treatment of prostate disease and methods of use
KR20010071512A (en) Brachytherapy Device Including An Anti-Static Handle
EA034223B1 (en) Device for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye
WO2010078048A2 (en) Apparatus and method for concurrent tensive and compressive immobilization of the breast in imaging and intervention
JP2007535334A (en) Seed and spacer placement for brachytherapy
CN109674539B (en) Tumor marking device
CN205672346U (en) Recyclable conformal radiation particle cabin
JP2016032595A (en) Intraluminal spacer for radiotherapy
CN208552887U (en) Multichannel vagina after-loading therapy device
CN215741340U (en) Combined vagina treatment device
CN211796759U (en) Puncture device for surgical clinic
JP2009525801A (en) Apparatus for monitoring patient status and treatment based on the status
CN213554838U (en) Intra-cavity combined tissue intercropping brachytherapy multi-cavity vaginal mold
CN106621076A (en) Cobalt-zirconium gold marker implant and gold marker implantation apparatus
CN207520457U (en) Cobalt zirconium molybdenum alloy mark
CN207085091U (en) Tumor marker device
CN106730373B (en) Cobalt zirconium molybdenum alloy mark
CN211327752U (en) Radioactive particle and radioactive particle puncturing implantation needle
CN207101641U (en) A kind of titanium mark implant
CN106880907B (en) A kind of dept. of radiology's radiotheraphy device
CN214971248U (en) Head paste for head radiotherapy synchronous electric field treatment simulation positioning
CN106361416B (en) The minimally invasive micro multiple target point injecting systems of intracerebral for stereotaxis navigation equipment

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant